Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

After years of wide-open compounding, regulators say they’re ready to enforce limits and restore control over the fast-growing GLP-1 market.

Please provide your email address to receive an email when new articles are posted on . As of the end of October, 28 deaths resulting from the use of poorly prepared compounded medications by a ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Pharmaceutical companies in Europe are blocking the sale of drugs used for lethal injection in the U.S. That has states that use the drugs turning to compounding pharmacies to create them. David ...

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...

U.S. Compounding Pharmacy Market · GlobeNewswire Inc. Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "U.S. Compounding Pharmacy Market - Industry Outlook & Forecast 2024-2029" report has been added to ...

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...